Search

everythinglearnresearchcommunity

for

Search:↓

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

The conclusion is that certain traits, including perceived facial aging and BMI, are linked to perceived youthfulness differently in men and women.

The conclusion is that certain traits, including perceived facial aging and BMI, are linked to how youthful people look, with some differences between males and females.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Fat tissue vesicles protect skin from UV damage better than stem cell vesicles.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

The Rotterdam Study aims to understand various diseases in older adults.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Vitamin D might help regulate insulin in the body, but taking Vitamin D supplements doesn't clearly prevent or improve type 2 diabetes. More research is needed.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

Women with pattern hair loss may have more stress in their bodies due to a lack of NRF2, a protein. Eating healthy and losing weight could help reduce this stress and improve hair loss. NRF2 boosters might also help treat this type of hair loss.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

A 3-month treatment improved PCOS symptoms and reduced certain immune proteins.